1st Quarter - Report

DOTCHIN & ASSOCIATES, LLC for EMERGENT BIOSOLUTIONS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Disaster Planning/Emergencies DIS

FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government NDAA - provisions related to biological and chemical defense Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines

LobbyistCovered position, as disclosed
ROBERT J. DOTCHIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6074 (116th), S. 3548 (116th)

Health Issues HCR

FDA regulatory issues Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines

LobbyistCovered position, as disclosed
ROBERT J. DOTCHIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense Department of Defense appropriations for Medical Countermeasures H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government NDAA - provisions related to biological and chemical defense Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines

LobbyistCovered position, as disclosed
ROBERT J. DOTCHIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3548 (116th), H.R. 6074 (116th)

Homeland Security HOM

FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government NDAA - provisions related to biological and chemical defense Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines

LobbyistCovered position, as disclosed
ROBERT J. DOTCHIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3548 (116th), H.R. 6074 (116th)

Defense DEF

NDAA - provisions related to biological and chemical defense Department of Defense appropriations for Medical Countermeasures

LobbyistCovered position, as disclosed
ROBERT J. DOTCHIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.